Article
Targeted Therapies in Pancreatic Cancer: A New Era of Precision Medicine
25 Sept 2024
Abstract excerpt
Pancreatic ductal adenocarcinoma (PDAC), a leading cause of cancer mortality in the United States, presents significant treatment challenges due to its late diagnosis and poor prognosis. Despite advances, the five-year survival rates remain dismally low, with only a fraction of patients eligible for potentially curative surgical interventions. This review aims to comprehensively examine the current landscape of...
Topics
Join the communities discussing this publication.